Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13,892 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutraceuticals: Pharmacologically Active Potent Dietary Supplements.
Chandra S, Saklani S, Kumar P, Kim B, Coutinho HDM. Chandra S, et al. Among authors: kumar p. Biomed Res Int. 2022 Jul 4;2022:2051017. doi: 10.1155/2022/2051017. eCollection 2022. Biomed Res Int. 2022. PMID: 35832855 Free PMC article. Review.
Process evaluation of a complex, multilevel, multicomponent scheme for the prevention and control of non-communicable diseases in Tamil Nadu, India: A mixed-methods protocol.
Ponnaiah M, Chadwick J, Mohan M, Bagepally BS, Muthappan S, Prabakaran N, Selvam J, Vasu H, Virumbi V, Bhatnagar A, Nair D, Chitra, Kumar PS, Viswanathan V, Krishnaraj K, Harisundari VP, Selvavinayagam TS, Ahamed D, Uma S, Kumar PS, Murhekar M. Ponnaiah M, et al. Among authors: kumar ps. MethodsX. 2024 May 1;12:102739. doi: 10.1016/j.mex.2024.102739. eCollection 2024 Jun. MethodsX. 2024. PMID: 38737485 Free PMC article.
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK.
Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA, Graham CD, McCracken LM, Goldstein LH, Al-Chalabi A, Orrell RW, Williams T, Noad R, Baker I, Faull C, Lambert T, Chhetri SK, Ealing J, Hanratty A, Radunovic A, Gunawardana N, Meadows G, Gorrie GH, Young T, Lawrence V, Cooper C, Shaw PJ, Howard RJ; COMMEND Collaboration Group. Gould RL, et al. Among authors: kumar p. Lancet. 2024 May 9:S0140-6736(24)00533-6. doi: 10.1016/S0140-6736(24)00533-6. Online ahead of print. Lancet. 2024. PMID: 38735299
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial.
Molina JM, Rizzardini G, Orrell C, Afani A, Calmy A, Oka S, Hinestrosa F, Kumar P, Tebas P, Walmsley S, Grandhi A, Klopfer S, Gendrano I, Eves K, Correll TA, Fox MC, Kim J. Molina JM, et al. Among authors: kumar p. Lancet HIV. 2024 May 8:S2352-3018(24)00031-6. doi: 10.1016/S2352-3018(24)00031-6. Online ahead of print. Lancet HIV. 2024. PMID: 38734015
13,892 results
You have reached the last available page of results. Please see the User Guide for more information.